Wildcat Capital Management, LLC

13D and 13G Filings

Investors who own more than 5% of a class must file a Schedule 13D or 13G. The latest filing for each security since 12/18/2024, newest first.

Issuer	Symbol	CUSIP	% of Class	Shares	Form	Filed
Silexion Therapeutics Corp 13D/A SLXN · G1281K122	SLXN	G1281K122	1.3%	113,428	13D/A	6/26/2025 Event 6/26/2025
Wildcat Capital Management, LLC			1.3%	113,428
Wildcat Partner Holdings, LP			1.3%	113,428
Leonard A. Potter			1.3%	113,428
Vicapsys Life Sciences, Inc. 13G VICP · 92560A106	VICP	92560A106	18.8%	6,070,588	13G	3/21/2025 Event 4/20/2020
Wildcat Capital Management, LLC			18.8%	6,070,588
Wildcat Partner Holdings, LP			18.8%	6,070,588
Leonard A. Potter			18.8%	6,070,588